Whiteoak Capital Pharma And Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 12-02-2026
NAV ₹13.74(R) -0.12% ₹14.24(D) -0.12%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 9.59% -% -% -% -%
Direct 11.51% -% -% -% -%
Nifty Pharma TRI 6.61% 23.09% 12.67% 14.95% 8.03%
SIP (XIRR) Regular 5.41% -% -% -% -%
Direct 7.26% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 486 Cr

No data available

NAV Date: 12-02-2026

Scheme Name NAV Rupee Change Percent Change
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 13.74
-0.0200
-0.1200%
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth 14.24
-0.0200
-0.1200%

Review Date: 12-02-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 0.66 -1.09
-0.30
-4.35 | 2.27 5 | 13 Good
3M Return % -2.86 -0.76
-2.92
-6.34 | 0.34 8 | 13 Good
6M Return % -0.49 3.12
-1.44
-5.15 | 1.74 5 | 13 Good
1Y Return % 9.59 6.61
6.01
-1.70 | 12.43 2 | 13 Very Good
1Y SIP Return % 5.41
1.58
-5.52 | 9.40 2 | 13 Very Good
Return data last Updated On : Feb. 12, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Dec. 31, 2025
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 0.81 -1.09 -0.19 -4.24 | 2.42 5 | 13 Good
3M Return % -2.44 -0.76 -2.61 -6.03 | 0.64 7 | 13 Good
6M Return % 0.37 3.12 -0.80 -4.52 | 2.34 4 | 13 Very Good
1Y Return % 11.51 6.61 7.38 -0.39 | 13.76 2 | 13 Very Good
1Y SIP Return % 7.26 2.92 -4.23 | 10.70 2 | 13 Very Good
Return data last Updated On : Feb. 12, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Dec. 31, 2025
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Whiteoak Capital Pharma And Healthcare Fund NAV Regular Growth Whiteoak Capital Pharma And Healthcare Fund NAV Direct Growth
12-02-2026 13.743 14.236
11-02-2026 13.759 14.253
10-02-2026 13.592 14.079
09-02-2026 13.543 14.027
06-02-2026 13.269 13.741
05-02-2026 13.316 13.79
04-02-2026 13.338 13.811
03-02-2026 13.357 13.83
02-02-2026 12.985 13.444
30-01-2026 13.071 13.532
29-01-2026 12.931 13.387
28-01-2026 13.056 13.516
27-01-2026 13.033 13.491
23-01-2026 13.037 13.493
22-01-2026 13.188 13.648
21-01-2026 13.062 13.517
20-01-2026 13.175 13.633
19-01-2026 13.463 13.931
16-01-2026 13.562 14.031
14-01-2026 13.694 14.167
13-01-2026 13.691 14.163
12-01-2026 13.653 14.122

Fund Launch Date: 06/Feb/2024
Fund Category: Pharma Fund
Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Description: An open ended equity scheme investing in Pharma and Healthcare sector
Fund Benchmark: BSE Healthcare Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.